Clinical trials: Complication of Hemodialysis
Covid19, Vaccine Reaction
Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis
The aim of the study is to evaluate the level of neutralizing antibody against SARS-CoV-2 after COVID-19 vaccination in patients under hemodialysis.
- Conditions
- Covid19, Vaccine Reaction, Hemolysis, End-stage Renal Disease
- Trial name
- NCT04871945
- Testing
- Elecsys Anti-SARS-CoV-2 S (Roche Diagnostics GmbH, Mannheim, Germany), 2) ACCESS SARS-CoV-2 IgG II (Beckman Coulter, Inc. USA)
- Where
- South Korea
- Volunteers
- 31 people, healthy volunteers welcome
- Sponsor
- Hanyang University Seoul Hospital
End Stage Renal Disease
Xeltis Hemodialysis Access Graft (aXess) US Study
A multi-center, prospective, single-arm, non-randomized, staged, pivotal clinical study to evaluate the safety and performance of the aXess graft in subjects aged 18 and above, diagnosed with end-stage kidney disease, and…
- Trial name
- NCT06494631
- Testing
- Xeltis Hemodialysis Access (aXess) graft
- Where
- 7 sites in United States
- Volunteers
- 140 people
- Sponsor
- Xeltis
End-Stage Kidney Disease, Hyperphosphatemia
Explore the Effectors of The Transtheoretical Model on Nutritional Education in Patients on Hemodialysis
The purpose of this study is to assess the improvement degree of nutritional care program on the nutritional status and eating habits of hemodialysis patients
- Trial name
- NCT05897502
- Testing
- multimedia education
- Where
- Taiwan
- Volunteers
- 43 people
- Sponsor
- Liu, Liu-Yin
Kidney Failure, Chronic, Depression
Cognitive-behavioral (CBT) in ESRD Patients With Depression
Depression is common in end-stage renal disease (ESRD) patients and has a negative effect on the quality of life, functional ability, and mortality, with a prevalence rate as high as 20-25%.
- Conditions
- Kidney Failure, Chronic, Depression, Quality of Life
- Trial name
- NCT02011139
- Testing
- Cognitive-behavioral group therapy
- Where
- South Korea
- Volunteers
- 15 people
- Sponsor
- Seoul National University Boramae Hospital
Acute Kidney Injury
Hemodynamic and Respiratory Tolerance of Intermittent Hemodialysis in Critically Ill Patients
Acute kidney injury (AKI) affects up to 30% of critically ill patients and is associated with increased rates of mortality. Up to 60% of patients with AKI will ultimately require renal replacement therapy (RRT).
- Trial name
- COOBrA (NCT04444765)
- Testing
- Collection of clinical and biological data during renal replacement therapy sessions
- Where
- France
- Volunteers
- 200 people
- Sponsor
- University Hospital, Toulouse
Anemia, End Stage Renal Disease
16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis
The purpose of this study is to evaluate the hemoglobin response (efficacy), safety, and tolerability of orally administered AKB-6548 in participants with end stage renal disease undergoing chronic hemodialysis.
- Trial name
- NCT02260193
- Testing
- AKB-6548
- Where
- 16 sites in United States
- Volunteers
- 94 people
- Sponsor
- Akebia Therapeutics
Complication of Dialysis
Functional Electrical Stimulation (FES) Exercise Training in Hemodialysis Patients
Both strength training and endurance exercise training are commonly prescribed to improve strength and function in patients with physical limitations caused by chronic disease or disability including chronic kidney disease (CKD).
- Trial name
- NCT01956214
- Testing
- FES Exercise, Mock FES Exercise
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- University of Illinois at Urbana-Champaign
Renal Dialysis, Renal Failure, Chronic
Tobramycin Administered at the Beginning of Dialysis
The purpose of the study is to evaluate whether the administration of a full tobramycin dose (5 mg/kg) during the first 30 minutes of a hemodialysis session provides favorable pharmacokinetic parameters in subjects with end-stage…
- Trial name
- ESRD (NCT03904836)
- Testing
- Tobramycin
- Where
- Canada
- Volunteers
- 11 people
- Sponsor
- Maisonneuve-Rosemont Hospital
Anemia of Chronic Kidney Disease, Chronic Renal Failure
Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients
This observational study aims to compare long-acting darbepoetin alpha versus short-acting epoetin alpha erythropoietin-stimulating agents in Egyptian hemodialysis patients.
- Conditions
- Anemia of Chronic Kidney Disease, Chronic Renal Failure, Chronic Renal Failure Anemia
- Trial name
- NCT05699109
- Where
- Egypt
- Volunteers
- 127 people
- Sponsor
- Helwan University
Renal Disease, High Blood Pressure
Blood Pressure Change and Outcome
Hyper- and hypotension are important predictors of survival in non-ESRD (end stage renal disease) population. In dialysis patients, however, it has been shown that higher blood pressure levels may actually be beneficial to…
- Trial name
- BP (NCT01330004)
- Where
- United States
- Volunteers
- 12,695 people
- Sponsor
- Renal Research Institute
End-Stage Kidney Disease (ESKD)
Virtual Reality-Guided Imagery in Hemodialysis Patients ( VRGI-HD )
This randomized controlled trial aims to evaluate the effect of virtual reality guided imagery on selected health outcomes among adult patients receiving maintenance hemodialysis.
- Trial name
- NCT07867444
- Testing
- virtual reality-guided imagery (VRGI)
- Volunteers
- 80 people
- Sponsor
- Islamic University of Najaf
End-Stage Renal Disease
Vitamin D3 Supplementation in Dialysis Patients
Vitamin D deficiency is highly prevalent among dialysis patients, and has been associated with cardiovascular risk factors such as increased aortic pulse wave velocity, blood pressure, inflammation, and brain natriuretic peptide.
- Trial name
- NCT01312714
- Testing
- Cholecalciferol
- Where
- Denmark
- Volunteers
- 64 people
- Sponsor
- Regional Hospital Holstebro
Peripheral Artery Disease, End Stage Renal Disease on Dialysis
A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease
A cross-sectional, non-interventional study to assess walking performance, vascular function, and lower limb calcification in subjects with peripheral artery disease and end-stage kidney disease (PAD-ESKD) receiving hemodialysis.
- Trial name
- NCT04487301
- Where
- 7 sites in United States
- Volunteers
- 36 people
- Sponsor
- Sanifit Therapeutics S. A.
Chronic Kidney Disease
Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients
Use of Paricalcitol in stage Vd Chronic Kidney Disease patients, over the effect of inflammatory and oxidative stress parameters.
- Trial name
- SENPARIC (NCT01820767)
- Testing
- Paricalcitol, Paricalcitol, atorvastatin, Atorvastatin
- Where
- 2 sites in Spain
- Volunteers
- 31 people
- Sponsor
- Ricardo Mouzo Mirco
Chronic Kidney Failure
Evaluation of the Biocompatibility of Cartridge Blood Set Versus Standard Blood Line
The primary objective is to collect data to evaluate the biocompatibility of two types of blood circuit, already on the market.
- Trial name
- NCT00804453
- Testing
- Cartridge blood set, Standard blood line
- Where
- France
- Volunteers
- 16 people
- Sponsor
- Vantive Health LLC
End Stage Renal Disease
Treatment Choice and Outcomes for ESRD: Evidence From the First Year of a Nationwide Randomized Evaluation
The investigators plan to analyze the first year of a nationwide randomized-controlled trial of end stage renal disease (ESRD) treatment choice model (ETC).
- Trial name
- NCT05005572
- Testing
- Payment adjustment for home dialysis and transplant
- Where
- United States
- Volunteers
- 18,621 people
- Sponsor
- Amy Finkelstein
Hemodialysis Complication
A Study of Compound Amino Acid Capsule on Maintenance Hemodialysis Patients
The goal of this retrospective cohort study is to investigate the effects of compound amino acid capsule on nutrition, calcium and phosphorus metabolism in maintenance hemodialysis(MHD) patients.
- Trial name
- NCT05874557
- Volunteers
- 40 people
- Sponsor
- RenJi Hospital
Chronic Kidney Disease
Study of Phosphate Levels in Patients With Chronic Kidney Disease
The purpose of this study is to investigate the ability of different doses of PA21 to lower serum phosphate levels, in patients with chronic kidney disease on maintenance hemodialysis.
- Trial name
- PA21 (NCT00824460)
- Testing
- 1.25 g PA21 (250 mg iron), 5.0 g PA21 (1,000 mg iron), 7.5 g PA21 (1,500 mg iron)
- Where
- 60 sites in United States, Bulgaria and 7 more
- Volunteers
- 154 people
- Sponsor
- Vifor Pharma
Renal Disease, Dialysis; Complications
The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis
In this study are included patients on hemodialysis with anemia (levels of Hemoglobin<110). After baseline measurements tha patients take Standardized Aronia melanocarpa extract for one mont and then all measurements were…
- Conditions
- Renal Disease, Dialysis; Complications, Anemia
- Trial name
- NCT04208451
- Testing
- Alixir 400 Protect
- Where
- Serbia
- Volunteers
- 30 people
- Sponsor
- University of Kragujevac
End Stage Renal Disease
Dehydr8 and Deactiv8
Managing fluid status is a complex but fundamental part of the clinical care of people receiving haemodialysis (HD). Day-to-day fluid management is usually based on the concept of 'target weight' - the weight used to determine…
- Trial name
- NCT03179072
- Where
- United Kingdom
- Volunteers
- 20 people
- Sponsor
- University of Portsmouth
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.